HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Review of NHANES data links metformin use to lower mortality and inflammatory markers in type 2 diabetes
Metformin use linked to lower death risk and better inflammation markers in U.S. adults with diabetes
This review of NHANES 2013-2018 data (2,116 adults) found that metformin use was associated with lower all-cause and cardiovascular mortalit…
New analysis of U.S. adults with diabetes suggests metformin use connects to lower death risk and improved inflammation markers, though more…
medRxiv
May 1, 2026
Gastroenterology
Sys. Review
Narrative review discusses pharmacological and lifestyle interventions for type 2 diabetes and psychological health
New hope for diabetes patients struggling with anxiety and depression
This narrative review examines the relationship between type 2 diabetes and conditions such as anxiety, depression, and cognitive impairment…
Diabetes drugs that control blood sugar might also help improve mood and reduce anxiety for patients living with the condition.
Frontiers
Apr 30, 2026
Cardiology
Sys. Review
Narrative review examines multimorbidity impact on sepsis morbidity and mortality outcomes
Sepsis Risk Skyrockets When You Have Multiple Chronic Conditions
This narrative review synthesizes evidence regarding sepsis in patients with multimorbidity including type 2 diabetes and heart failure.
Common chronic diseases like diabetes and heart failure create hidden traps that make sepsis much harder to fight and treat.
Frontiers
Apr 29, 2026
Diabetes & Endocrinology
Guideline
Guideline narrative review discusses diabetes risks from immunosuppressive therapy in kidney transplant recipients
Guidelines address diabetes risks in kidney transplant patients
This publication is a narrative review guideline addressing Post-transplant diabetes mellitus and Type 2 Diabetes.
New guidance outlines considerations for kidney transplant patients dealing with diabetes and medication risks associated with therapy.
Frontiers
Apr 29, 2026
Cardiology
Cohort
Baseline vitamin D levels linked to semaglutide glycemic and weight outcomes in type 2 diabetes
Higher Vitamin D levels help Semaglutide work better for diabetes
This observational cohort study of 5,384 adults with type 2 diabetes found that higher baseline vitamin D levels were associated with greate…
New data shows higher Vitamin D levels help Semaglutide lower blood sugar and weight more effectively in diabetes patients.
Frontiers
Apr 28, 2026
Diabetes & Endocrinology
Review of miRNA associations with high-risk diabetes profiles in midlife women
MicroRNA markers linked to diabetes and depression risk in midlife women
This observational study review examines microRNA associations with high-risk profiles in women aged 40 to 64 years within the Diabetes Prev…
Specific microRNA markers were found linked to higher odds of a high-risk profile for diabetes and depression in midlife women.
medRxiv
Apr 28, 2026
Diabetes & Endocrinology
RCT
High LDL-C to HDL-C ratio linked to cardiovascular events in type 2 diabetes with retinopathy
High cholesterol ratio raises heart risk in diabetics
This post hoc analysis of a randomized controlled trial in 5,006 high-risk type 2 diabetes patients with diabetic retinopathy found that a h…
A routine cholesterol test may reveal hidden heart danger in people with diabetes, even when taking cholesterol drugs.
Apr 27, 2026
Diabetes & Endocrinology
Phase III
Semaglutide high dose for weight reduction in people with Type 2 Diabetes
New drug helps obese diabetics lose weight and control sugar
This randomized controlled trial in 512 people with excess weight and Type 2 Diabetes compared high-dose semaglutide to placebo and lower do…
New research shows a specific injection helps people with obesity and diabetes lose weight and control their blood sugar levels better than …
CT.gov
Apr 27, 2026
Nephrology
Meta-analysis
Individual-participant data meta-analysis shows blood-pressure lowering reduces cardiovascular risk in CKD and non-CKD populations
Blood pressure drugs protect kidneys and hearts across all stages
This individual-participant data meta-analysis pooled results from 46 randomised trials involving 285,124 participants to evaluate…
Lowering blood pressure protects the heart and kidneys across all stages of kidney disease, but the benefit is weaker in patients who also h…
Apr 27, 2026
Diabetes & Endocrinology
Cohort
Machine learning model improves early detection of occult diabetic kidney disease in hospitalized patients
New Tool Spots Hidden Kidney Disease in Type 2 Diabetes Earlier
This retrospective multicenter cohort study evaluated a machine learning model using routine clinical and laboratory data to detect occult d…
A new calculator spots hidden kidney damage in type 2 diabetes using routine blood tests, helping doctors act sooner.
Frontiers
Apr 27, 2026
Genetics & Precision Medicine
Cohort
GenMetS polygenic score association with cardiometabolic risk in Asian populations
New Genetic Score Predicts Heart Risk Decades Earlier in Asian Populations
This cohort study of 670,952 individuals investigated the association between the GenMetS polygenic score and cardiometabolic risk across th…
A new genetic score developed in young Asian women accurately predicts heart and diabetes risk from childhood through adulthood, filling a m…
medRxiv
Apr 27, 2026
Diabetes & Endocrinology
Observational study suggests multi-omic scores improve Type 2 Diabetes risk assessment in UK Biobank and MESA cohorts
Blood Test Could Predict Your Type 2 Diabetes Risk Better Than Genes Alone
This observational research article synthesizes findings from the UK Biobank and Multi-Ethnic Study of Atherosclerosis (MESA) regarding part…
A new blood test that combines genes with proteins and metabolism can more accurately predict type 2 diabetes risk and who may need insulin.
medRxiv
Apr 26, 2026